| Dr Michael Paul Suszter, DO | |
|
3373 Commerce Pkwy, Suite 2, Wooster, OH 44691-7130 | |
| (330) 804-9712 | |
| (330) 804-9717 |
| Full Name | Dr Michael Paul Suszter |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 3373 Commerce Pkwy, Wooster, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598991259 | NPI | - | NPPES |
| 0074565 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 34.010630 (Ohio) | Primary |
| 207X00000X | Orthopaedic Surgery | 20A10673 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
Louise A. Villejo, executive director of the Patient Education Office at The University of Texas MD Anderson Cancer Center, is the recipient of the 2010 Julie and Ben Rogers Award for Excellence in Education.
OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.
› Verified 1 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
Louise A. Villejo, executive director of the Patient Education Office at The University of Texas MD Anderson Cancer Center, is the recipient of the 2010 Julie and Ben Rogers Award for Excellence in Education.
OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Paul Suszter, DO 3373 Commerce Pkwy, Suite 2, Wooster, OH 44691-7130 Ph: (330) 804-9712 | Dr Michael Paul Suszter, DO 3373 Commerce Pkwy, Suite 2, Wooster, OH 44691-7130 Ph: (330) 804-9712 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
Louise A. Villejo, executive director of the Patient Education Office at The University of Texas MD Anderson Cancer Center, is the recipient of the 2010 Julie and Ben Rogers Award for Excellence in Education.
OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.
› Verified 1 days ago
Dr. James W Gesler, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3373 Commerce Pkwy, Suite 2, Wooster, OH 44691 Phone: 330-804-9712 Fax: 330-804-9717 | |
Dr. Owen W Logee, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3727 Friendsville Rd, Suite 2, Wooster, OH 44691 Phone: 330-202-3440 Fax: 330-202-3448 | |
Jeffrey L. Watts, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3373 Commerce Pkwy Ste 2, Wooster, OH 44691 Phone: 330-804-9712 Fax: 330-804-9811 | |
Dr. William J Skelly, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3727 Friendsville Rd, Suite 2, Wooster, OH 44691 Phone: 330-202-3440 Fax: 330-202-3448 | |
Dr. Bradley Arthur Pierce, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 721 E Milltown Rd, Wooster, OH 44691 Phone: 330-287-4735 | |
Marcus Newton, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3727 Friendsville Rd, Suite 5, Wooster, OH 44691 Phone: 330-202-3420 Fax: 330-202-3347 |